Evaluation of a screening algorithm using the Strengths and Difficulties Questionnaire to identify children with mental health problems: A five-year register-based follow-up on school performance and healthcare use
Authors:
Rasmus Trap Wolf aff001; Pia Jeppesen aff002; Dorte Gyrd-Hansen aff001; aff004; Anne Sophie Oxholm aff001
Authors place of work:
University of Southern Denmark, Department of Public Health, Danish Centre for Health Economics, Odense, Denmark
aff001; Child and Adolescent Mental Health Centre, Mental Health Services Capital Region of Denmark, Copenhagen, Denmark
aff002; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
aff003; Centre for Clinical Research and Prevention, Capital Region of Denmark, Copenhagen, Denmark
aff004
Published in the journal:
PLoS ONE 14(10)
Category:
Research Article
doi:
https://doi.org/10.1371/journal.pone.0223314
Summary
Background
Treatment of mental health problems (MHP) is often delayed or absent due to the lack of systematic detection and early intervention. This study evaluates the potential of a new screening algorithm to identify children with MHP.
Methods
The study population comprises 2,015 children from the Copenhagen Child Cohort 2000 whose mental health was assessed at age 11–12 years and who had no prior use of specialised mental health services. A new algorithm based on the Strengths and Difficulties Questionnaire (SDQ) is utilised to identify MHP by combining parent-reported scores of emotional and behavioural problems and functional impairments. The screening is done on historical data, implying that neither parents, teachers nor health care professionals received any feedback on the screening status. The screening status and results of an IQ-test were linked to individual-level data from national registries. These national registers include records of each child’s school performance at the end of compulsory schooling, their health care utilisation, as well as their parents’ socio-economic status and health care utilisation.
Results
10% of the children screen positive for MHP. The children with MHP achieve a significantly lower Grade Point Average on their exams, independently of their IQ-score, perinatal factors and parental characteristics. On average, the children with MHP also carry higher health care costs over a five-year follow-up period. The higher health care costs are only attributed to 23% of these children, while the remaining children with MHP also show poorer school performance but receive no additional health care.
Conclusions
The results demonstrate that children with MHP and a poor prognosis can be identified by the use of the brief standardised questionnaire SDQ combined with a screening algorithm.
Keywords:
Schools – children – Mental health and psychiatry – Health screening – Human performance – Child psychiatry – Health care utilization – Health care sector
Introduction
Today more than 13% of children and adolescents worldwide are affected by mental disorders at any given time [1] with a significantly negative impact on their quality of life [2]. Several studies show that children’s mental health problems lead to a higher risk of mental disorders later in life [3–9]. The median age of onset of anxiety, mood and behavioural disorders occur before age 14 years [10]. Despite the progress in the development and positive evaluation results of early treatment programs for mental health problems in childhood [11,12], such programs are not offered systematically and on a wide scale in Denmark or, to the best of our knowledge, in any other countries.
There is a growing awareness of the potentials of preventive interventions to improve children’s mental health [11]. Specifically, on the potential of implementing them in ‘stepped-care models’ that offer interventions on increasing intensity levels ranging from general counseling to specialised mental health care, and with indicated prevention and early treatments as an intermediate step to children with common emotional and behavioral problems [13]. A systematic and wide-scale implementation of a stepped care model for service delivery needs to consider the complexities of childhood mental health problems. Children usually do not present with a recent-onset and well-defined single disorder. More commonly, the children have a long history of several problems, distress and impairments below or above diagnostic thresholds [13]. Thus, the ‘matching’ of the intervention to the children’s fluctuating and complex problems is not straight forward. A systematic approach to identifying the children in need of interventions that are beyond prevention and counseling is therefore a necessary part of a successful stepped-care model.
For more than a decade it has been discussed how to identify mental health problems at an early stage among school children [14]. As outlined in a recent review there exists several studies evaluating different screening programs [15]. However, the quality of these evaluations is poor. The majority of the evaluations are based on cross-sectional study designs, and the few existing cohort studies include short follow-up periods and/or are dependent on self-reported outcomes [15]. Furthermore, the existing evaluations focus on diagnosis or access to mental health care. This could be problematic outcomes, as not all children in need of mental health care are likely to receive it [16–18]. Moreover, children with problems below the threshold for diagnosis may still require mental health care to avoid major difficulties later in life [9,19].
This study evaluates the potential of a new screening algorithm to identify children with sub-threshold and undiagnosed mental disorders, in this study referred to as mental health problems (MHP), in a general population. A unique combination of historical birth cohort data and high-quality data from national registers is used to mimic the performance of screening by analysing the later school performance and health care utilisation of the screened children. As neither parents, teachers nor health care professionals receive any feedback on the screening this allows for analyses of how the children who screen positive perform in school up to five years later and how they utilise the health care system in a naturalistic follow-up. The rich data allows analyses that controls for potential confounders, i.e. the children’s IQ, perinatal factors and their parents’ health care utilisation and socio-economic characteristics. The methods section provides the precise definitions of the potential confounders.
The screening is based on parent-reported answers to the Strength and Difficulties Questionnaire (SDQ) and an algorithm, that combines scores of emotional and behavioural problems with functional impairments and uses cut-off based on population studies. The children’s later school performance is investigated as a primary indicator of the long-term outcome of the screening for MHP in preadolescence. As previous studies find an association between children’s MHP and their school performance [20–22], and school performance and schooling are known to be comprehensive predictors for the rest of a child’s life with respect to both wealth, health, and happiness [23–25], this indicator is well-suited for the evaluation of the screening. The children’s health care service utilisation during the five-year follow-up period is analysed for two purposes. First, to investigate whether and when the children that screen positive for MHP get access to specialised mental health care. Thereby the potential for early treatment can be assessed. Second, to investigate whether a different health care utilisation pattern is observed for the children that screen positive in the health care system.
Materials and methods
Ethics approval and consent to participate
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/ or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by The Danish Data Protection Agency (J.nr. 2010-41-4438) and by the Capital Region of Denmark (J.nr. 2007-58-0015). The National Committee on Health Research Ethics was consulted (J.nr. H-C-FSP-2010) in accordance with national guidelines. Participation was voluntary, and data was kept confidential. According to Danish legislation, individual informed consent or additional permission from the National Committee on Health Research Ethics is not required for registry-based studies. The parents gave oral informed consent to the study participation. Separate written consent was not required by the ethical committee. Moreover, the written information given to the participants stated that the participation in the study is voluntary, that by answering the questionnaires consent is given and consent can be withdrawn at any time.
Data
The Copenhagen Child Cohort
The Copenhagen Child Cohort (CCC2000) is a Danish birth cohort that includes all children born in 16 municipalities in the former Copenhagen County in the year 2000. In total, the cohort comprises 6,090 children, and constitutes 9% of all children born in Denmark that year. The cohort is representative of the general Danish population born that year in regards to both gender and a number of key perinatal factors such as age of parents and perinatal illness. Skovgaard et al. [26]provide further information on the cohort at birth. The main purpose of CCC2000 is to study the presentation, developmental pathways and risk mechanisms of psychopathology longitudinally from birth. As part of the follow up studies of the cohort, the parents of the children were invited to complete the “Strengths and Difficulties Questionnaire” (SDQ) at different points in time, i.e. when the children are aged 5–7 and 11–12 years. The present study uses SDQ responses from when the children were aged 11–12 years. In total, parents of 2,126 children (35%) completed SDQ at the 11–12 years follow-up.
The screening algorithm
We use SDQ to define whether or not a child screens positive for MHP. SDQ is widely used and validated as a tool to identify and assess children with MHP in both clinical samples and in general population-based samples [27–32]. SDQ contains 25 items, which cover five subscales relating to the children’s emotional problems, peer problems, behavioural problems, hyperactivity and pro-social behaviour. Responses to the subscales on emotional problems, peer problems, behavioural problems, and hyperactivity can be used to calculate a total difficulties score. Each subscale score ranges from 0–10, implying that the total difficulties score ranges from 0 to 40 [33].
We use an extended version of SDQ, which also includes an impact assessment to evaluate how much the identified mental difficulties interfere with the child’s everyday life. A functional impairment score is calculated from five items on whether the difficulties upsets or distresses the child and how much the difficulties interfere with home life, friendships, classroom learning, and leisure activities. Each item is scored on a scale from 0 to 2. To score 1 or 2, the interference from the difficulties in that domain must be assessed to either “quite a lot” or “a great deal” [28,34].
The present study defines MHP as having a functional impairment score of at least 1 in combination with at least one of the following scores: a total difficulties score of at least 14 and/or an emotional problem score of at least 5 and/or a behavioural problem score of at least 3. This definition is based on age-matched populations in Denmark, Germany and the UK [35–37], such that scoring above the cut-off implies that the children’s mental health state is ranked among the 10% of the poorest in these populations. This definition of MHP is also used in an on-going Danish randomized, clinical trial of an early treatment intervention for children with MHP (Trial ID: NCT03535805).
Based on the above criterion, we define children as either having MHP (screening positive) or not (screening negative) at time of reporting, i.e. at age 11–12 years. Thus, we do not distinguish between different levels of MHP in this study.
School performance
In Denmark, it is compulsory to attend school for nine years, from the age of 7 years to 15 years. The majority of Danish children attend public schools, which are fully funded through taxes. Private schools are also heavily subsidised. We retrieve information on each child’s attendance and grades for each final exam from their compulsory schooling from the Danish Education Registers [38]. This information includes test scores up until summer 2017, where the children were between the age of 16.5 years and 17.5 years and thus, expected to have finished compulsory schooling.
At the end of compulsory schooling (9th grade), there are eight mandatory exams for all pupils distributed across four subjects: Danish, Mathematics, English and Physics/Chemistry. Following the Danish Ministry of Education that uses at least four exams to calculate the national Grade Point Average (GPA), we classify children who have not attended at least four of the eight mandatory exams as not having completed the 9th grade exams. Each exam results in a grade based on the Danish 7-point grading scale. The 7-point scale consists of seven grades: −03, 00, 02, 4, 7, 10, 12. These are equivalent to the following ECTS grades: F, Fx, E, D, C, B, A [39]. We calculate the children’s GPA from the 9th grade mandatory exams (results from at least four exams) as a school performance outcome.
Health care utilisation
In Denmark the health care system is predominantly publicly financed by taxes, and information on individuals’ health care utilisation and associated unit costs are listed in administrative registers. This study defines health care utilisation as the costs incurred for both somatic and mental health care and in both the primary and secondary health care sector. As there is no available information on privately funded health care, we only include the costs of publicly funded care, with the exception of out-of-pocket spending on prescription medicine.
We analyse health care costs for the years 2012 to 2016 (equivalent to the five years post “screening”). We analyse the health care costs both at an aggregated level as total health care costs and in subsets based on sectors and specific types of mental health care, as outlined in section 2.4.1–2.4.3. We adjust all costs to 2016-prices using price- and wage-regulations of consumption prices from the Danish Regions and Statistics Denmark [40,41]. We convert the costs from Danish kroner (DKK) to Euros (€) using the currency rate DKK 100 = € 13.42.
We retrieve the costs of health care in the primary health care sector from the Danish National Health Service Register [42]. The costs are based on providers’ activity-based remuneration. We differentiate between specialised and non-specialised mental health treatment in primary care. Specialised mental health treatment includes services from psychiatrists and psychologists, whereas non-specialised mental health treatment includes services provided by all remaining primary health care providers, e.g. general practitioners.
We retrieve costs of prescription medication from the Danish National Prescription Registry [43]. This database contains information on all purchase of prescription medications. We use the retail price at the date of purchase to measure costs. Depending on the annual consumption, between 60% and 100% of the cost of prescription medication is subsidised. Hence, we analyse the total costs of prescription medication for each child, implying that we include both the public funding and out-of-pocket spending. As there is no available information on purchase of over-the-counter medication, we do not include costs of this type of medication.
Costs of hospital care are retrieved from the National Patient Register [44]. We differentiate between somatic care and mental health care in hospitals, as well as inpatient care and outpatient care. We compute costs of somatic care using the Danish System of Diagnostic Related Groups (DRG-tariffs). DRG-tariffs are unavailable for mental health care in Denmark. Instead, we use the National Board of Health’s per diem charge and ambulatory charge for mental health care to assess the costs of mental health care in hospitals.
Covariates
School performance and health care utilisation may be affected by factors that may also be associated with MHP. In an effort to isolate the effect of MHP status on subsequent outcomes, the analyses include several covariates derived from Statistics Denmark’s national registers. For the individual child, this includes dummies for the following: the child’s gender, whether the child is the first-born in the family, whether the child was born with low-birth-weight (<2,400 gram) (LBW) and/or was small-for-gestational-age (SGA), whether the child is second-generation immigrant (there are non-first generation immigrants in the cohort), and whether the child lived with both biological parents the 1st of January 2012.
For both biological parents of the child, we include dummies for the following: whether the parent received mental health care in a hospital during the years 1995 and 2011, whether the highest education in the beginning of 2012 was primary school (up to 9 years education), whether the parent was unemployed in 2011 (defined as unemployed for at least six months), and whether the parent was among the 25% with the highest total health care costs in the CCC2000 population (split by gender) from 2000 to 2011.
Children’s IQ is potentially a confounding variable when estimating the association between school performance and MHP. The Block Design (BD) test is a subtest of Wechsler Intelligence Scale for Children (WISC-III). The BD test is known to be highly correlated with IQ on the full Wechsler test of intelligence [45]. We therefore proxy the children’s IQ using results from the BD test, which was done face-to-face for those children in the cohort who accepted the invitation. The tests were done at approximately the same time as SDQ responses were completed by the parent.
Research design and data analysis
Study population
The focus of this study is to evaluate the potential of the screening process, we therefore exclude children who had already received specialised mental health care (SMHC) before the date of the parent completing SDQ. SMHC is defined as any contact with psychologists or psychiatrists in the primary health care sector or any contact to a hospital mental health care department. In total, 111 children (5.2%) had received SMHC at some point prior to the parents completing SDQ. We exclude these children from the study population, resulting in a study population of 2,015 children.
Statistical analyses
In an effort to isolate the effects of MHP on school performance and health care utilisation, we control for the covariates listed in Section 2.5. However, for most of these covariates, it remains unclear whether they confound an association between MHP, school performance and health care costs, or if the single covariate represents an intermediary step on a causal pathway. All analyses are therefore done using three different models: 1) a crude model, 2) a model that includes covariates for the child’s characteristics, and 3) a model that includes covariates for both the child’s and the parents’ characteristics.
For analyses of school performance, we also include the BD test score (IQ-proxy) in separate models, yielding two additional models: 4) a model including the IQ-proxy and the additional covariates for the child’s characteristics and 5) a “full model” including the child’s IQ-proxy and additional covariates for both the child’s and the parents’ characteristics. A total of 1,537 children (76.3% of the study population) completed a face-to-face BD test. Hence, the models that include the IQ-proxy are based on this smaller study population.
We also analyse the association between MHP and the outcomes based on whether the children with MHP received SMHC during the five-year follow-up period. For the group of children with MHP that received SMHC, we analyse whether there is a “window of opportunity” for early treatment of the children.
The comprehensive number of covariates in some of the models increases the risk of “over controlling” and thereby, possibly underestimating the associations. We therefore expect the true estimate to be somewhere in the range of the estimates from the different models. By presenting results from all models, we aim to explore the robustness of any significant associations found.
We measure the children’s school performance using two different outcome measures: 1) completion of the 9th grade exams and 2) the GPA from the 9th grade exams. We employ a logit regression to estimate the association of MHP with the completion of the exams, whereas we use an Ordinary Least Squares (OLS) regression to estimate the association between MHP and the GPA, which is measured on a continuous scale.
We measure the children’s health care utilisation in different parts of the health care sector. These data are heavily right-skewed, and some outcomes have a high proportion of zeros (corresponding to no consumption). We therefore employ both Generalized Linear Models (GLM) and two-part models combining a logit model with a GLM to estimate the association between MHP and the different types of health care utilisation.
We specify the GLM models based on the performance of GLMs with normal, gamma, Gaussian, and inverse Gaussian distributions combined with linear, log, power (0.5), and power (-1) links. Following Deb et al. [46], we choose the link function and distribution using Akaike Information Criteria, link-test, and Park’s modified test. For the analysis of the children’s total health care costs and primary health care sector care costs (without psychologist/psychiatrist), a GLM with log-link and gamma distribution performs best. For the rest of the health care costs outcomes, two-part models combining a logit and GLM with log-link and gamma distribution performs best.
Results
Descriptive statistics
Table 1 describes the study population split by whether or not the child screened positive for MHP at age 11–12 years. We categorise 9.6% of the full study population as having MHP. Several covariates are statistically significantly associated with having MHP. This includes being the first-born child in the family (including only child), not living with both biological parents, the mother having had contact to mental health hospital services, the mother’s highest educational attainment being primary school, the mother being unemployed, and either parent being among the 25% of parents with the highest health care costs in decade leading up to the screening. In the study population for which an IQ-proxy test score is available, the percentage of children with MHP is slightly lower than in the full study population.
Table 2 shows descriptive statistics for the outcome variables. A larger share of children with MHP do not manage to complete the 9th grade exams, and amongst those who do complete the exams, a lower GPA is attained. Furthermore, the average total health care costs from 2012 to 2016 is higher for children with MHP, and a higher share receive SMHC in the five-year period. We present statistical tests results for associations between these outcomes and MHP in the following sections.
School performance
The association between MHP and school performance is estimated using two different school outcomes. The first school outcome measures completion of the 9th grade exams. Table 3 shows the results. The three models without the IQ-proxy suggest that children with MHP have statistically significant higher odds of not completing the 9th grade exams. This difference is, however, statistically insignificant when controlling for the children’s IQ.
The second school outcome is the GPA for the children, who have completed the 9th grade exams. Table 4 shows a statistically significant negative association between MHP and the GPA. Across models, the marginal effect ranges from -0.98 grade point to -1.27 grade point.
Health care utilisation
Table 5 presents the results of the analyses of the association between MHP and the health care utilisation in the subsequent five years after the SDQ-screening (2012 to 2016). The association between MHP and total health care utilisation is statistically significant and ranges from €5,858 to €7,336 across models. We split the total health care utilisation into seven subcategories. The analyses of the subcategories provide information on which type of health care service drives the differences in the total health care costs. The results show that the higher costs for children with MHP are primarily driven by higher inpatient and outpatient mental hospital care. However, costs related to prescription medicines and utilisation in the primary sector, both specialised mental care and other types of care, are also positively associated with MHP. There is no statistically significant association found between MHP and utilisation of somatic hospital care during the five-year period of analysis.
Table 5 also shows that the results are robust across all models. The only exception is the association between MHP and utilisation of mental inpatient hospital care, which is statistically insignificant when controlling for both children’s and parents’ characteristics. This finding can, however, be explained by the relatively few children utilising mental inpatient hospital care compared to the large number of covariates in the model, which generates a large standard error.
Health care utilisation and specialised mental health care treatment
Table 5 shows that SMHC utilisation is the main driver of the higher health care utilisation of children with MHP. However, as reported in Table 2, only 22.7% of the children with MHP receive SMHC during the five-year follow-up period. To explore whether the children with MHP, who did not receive SMHC, receive more of other types of health care services, we split the analysis of the health care costs of children with MHP by whether or not they received SMHC. In these analyses, the reference group is still the “children with no MHP”.
Table 6 shows the results of the crude models, i.e. without controlling for child and parental characteristics. We find that the higher total health care costs for the whole group of children with MHP is driven by the group of children with MHP who received SMHC. Besides generating high costs through their use of SMHC, this group of children also have higher costs due to utilisation of the primary health care sector and prescription medicine, and they tend to use somatic outpatient health care services more. The larger group of children with MHP who did not receive SMHC (77.3%) do not receive more health care services of any kind compared to children with no MHP. The findings are robust to including controls for both child and parental characteristics, see Table D in S1 Table.
School performance and specialised mental health care treatment
The results of the analyses of health care utilisation show that 77.3% of the children with MHP do not receive any SMHC and do not utilise the health care system more than children without MHP during the five-year follow-up period. To investigate whether this subgroup of children with MHP have an unmet need for care, we use the children’s later school performance as an indicator of the consequences of their MHP at the age of 11–12 years. Thus, finding a negative association between having MHP without receiving SMHC and later school performance, compared to children with no MHP, will indicate that there is an unmet need for care.
We compare the school performance between children without MHP and the two groups of children with MHP, who are divided by whether or not they received SMHC during the five-year follow-up period. Tables 7 and 8 show the results. The group of children with MHP who did not receive SMHC does not have higher odds of not completing the 9th grade exams. The models without IQ-proxy shows a tendency towards a higher risk, but this tendency is statistically insignificant when controlling for IQ. However, the group of children with MHP who received SMHC have statistically significant higher odds of not having completed the 9th grade exams. The estimated odds ratio is almost halved after controlling for IQ. The statistical significance level is, however, independent of the chosen model.
In the analyses of GPA, shown in Table 8, we find a statistically significant negative association between MHP and GPA independently of whether or not the child has received SMHC. Amongst the children who have MHP but do not receive SMHC, the GPA score is between -0.90 and -1.29 grade points lower than non-MHP children, while it is between -1.17 and -1.35 grade points lower for the children with MHP who do receive SMHC.
Window of opportunity and diagnoses
To analyse the potential for earlier treatment of the children with MHP who receive specialised care within the five-year follow-up period, we analyse whether they receive the care with some delay compared to the timing of screening. The results include the 44 children with mental health problems and minimum one contact with SMHC. We find that the mean number of days between the parents’ completion of SDQ and their children’s first contact with SMHC was 945 days, and the median was 1,000 days. The 25% and 75% percentiles were 426 days and 1,311 days, respectively. Thus, the results show that both the average and median time span was more than two and a half years from when the parent responded to SDQ to the first contact with any SMHC.
Diagnoses are available for the children in the study population that received SMHC at a hospital. In total 16.8% of the children with MHP received a psychiatric diagnosis during the five-year follow-up period compared to 3.6% of the children we classify as not having MHP at age 11–12 years.
Of the 44 children with MHP receiving SMHC during the five-year follow-up period, 33 children (75%) received SMHC at a hospital. Thus, diagnoses are available for these children. They receive a broad variety of diagnoses: Hyperactivity disorders, adjustment reactions, pervasive developmental disorders, depressive disorders, psychotic disorders, and anxiety disorders are among the most frequent diagnoses. To comply with the data protection regulation, we refrain from reporting all specific diagnosis for this relatively small sample of individuals.
Discussion
Using parents’ responses to SDQ and the screening algorithm, we categorise 9.6% of the 11-12-year-old children in our study population as having MHP. We find that the children with MHP independent of potential confounders perform statistically significantly worse at the 9th grade exams, which are conducted about five years after the screening. This finding is in line with previous studies that have found an association between SDQ scores and school outcomes [21,22]. The results indicate that the screening algorithm succeed in identifying children that may benefit from an early intervention.
Children with MHP also exhibit a statistically significant higher utilisation of health care during the five-year follow-up period. Sub-group analyses show that the higher health care utilisation is entirely driven by the 22.7% of the children with MHP who receive SMHC during the follow-up period. The children we identified with MHP, who receive SMHC during the follow-up period, have their first contact with specialised care on average 2.5 years after the parent’s completion of SDQ. This indicates that there for the majority of the group is a ‘window-of-opportunity’ for an early intervention.
The 77.3% of children with MHP who do not receive any SMHC during the follow-up period also obtain a statistically significantly worse GPA at their 9th grade exams than children with no MHP. However, these children do not receive any other additional health care services, which indicates that they have unmet need for care throughout the follow-up period.
We find that the children with MHP that receive SMHC have worse school outcome than the children with MHP that do not receive SMHC. This finding should, however, not necessarily be interpreted as the SMHC having a negative effect on the children’s long-term outcome. It is more likely that the difference is due to confounding by indication, meaning that those who are affected the most from the MHP also are more likely to get access to SMHC doing the follow-up.
The results show that the screening algorithm combined with parental-responses to SDQ enables us to identify of a group of children with MHP and a poor prognosis based on their later school performances. In Denmark and all other countries, to the best of our knowledge, evidence-based early treatment programs are not being offered systematically. The results of our study indicate that when no systematic screening is in place, the majority of the children with MHP receive no care despite of a poorer prognosis. Furthermore, those who get access to SMHC get it with a delay, potentially due to the MHP having progressed in severity thus making them eligible for SMCH. In a future implementation of a stepped-care model a screening procedure, like the one presented, could play an important first step in the ‘matching’ of intervention and severity of MHP.
Strengths and limitations
A key strength of this study is the unique combination of cohort data including the face-to-face IQ-proxy test combined with the full register data on the children’s school performance and health care utilisation, as well as information on the broad range of socio-economic and health-related covariates related to both the children and their parents. Despite the small population groups in some analyses, the results remain robust in all analyses independent of the inclusion of potential confounders, which further strengthens our findings.
There are, however, also some limitations. Due to data limitations, we were unable to include costs of possible visits and treatments at privately funded psychiatrists and psychologist. As publicly funded counselling or preventive measures vary across municipalities and are not systematically reported, we were also unable to include this information. However, the municipalities do not provide any systematic evidence-based practices. Their services can be considered as a first step in a stepped-care model and do not have the characteristics of early treatment. The missing information will therefore not change any of our conclusions. As we miss the information on private and municipality costs, the cost estimates should, however, be interpreted from a public health care sector perspective.
The study population is part of the CCC2000, which is representative of the Danish population on several key characteristics. However, as our study population is limited to children whose parents’ respond to SDQ, our sample is not representative of the general population. On average, the study’s parents have a higher educational attainment, are less unemployed, and have fewer contacts to mental health care services than the general population (see Table E in S1 Table). We do, however, not see any reason for our findings to be less relevant for children with parents from lower socioeconomic groups. As these parents are likely to have fewer resources to cope with the challenges of MHP, the negative impact of MHP on children’s school performance could possibly be even worse for this group. Our sample size does not allow for comprehensive subgroup analysis of possible effect modifications between socioeconomic factors and MHP.
Screening tool and timing
This study evaluates the potential for identifying children, who could benefit from an early intervention, using the SDQ and a new screening algorithm. This approach has several appealing properties. First SDQ is relatively brief and can easily be distributed and quickly answered by parents. Secondly, the scoring of SDQ allows an algorithm that combines symptoms scores with the impairment score such that we can identify children both with a certain load of symptoms and who are affected in their daily lives. Third, SDQ can be used to assess a broad range of MHP. Thus, we identify a wide variety in types of diagnosis among the children that screened positive and received a mental disorder diagnosis doing the follow-up. It is, however, possible that other instruments and/or more sophisticated screening algorithms could be as good or better at identifying children in the need of early intervention for MHP.
This study bases its results on a screening of children at the age of 11–12 years. SDQ data are also available for the CCC2000 from when the children were aged 5–7 years (pre-school age). The choice of using the data from when the children were aged 11–12 years is based on the availability of the IQ-proxy test score. In an additional analysis, we estimate the association between MHP at aged 5–7 years (using the same SDQ cut-off, we identify 5.6% of the children with MHP) and later school performance without controlling for IQ and health care utilisation. Table F and G in S1 Table, report the results for children with MHP at age 5–7 years and their later outcomes.
We do not find any association between MHP identified at pre-school age and the children’s school performance in 9th grade. For health care utilisation, we find results similar to the ones we report for the children identified at age 11–12 years. More specifically, MHP at the pre-school age is associated with higher health care costs in the subsequent 11 years. The estimates are, however, statistically significantly lower than the ones we find when screening the older age group. Although far from conclusive, these findings suggest that the age of screening is an important factor, and that our definition of MHP might not be as predictive among a pre-school population. Future studies should investigate the age factor further, and studies focusing on early treatment should consider this factor in the identification of children with MHP.
Conclusions
This study provides evidence that supports the potential for systematically early identification of MHP among children. Future studies should conduct a more comprehensive psychopathological assessment of the children identified with the presented SDQ algorithm, to give a further understanding of the full potential of systematically early identification of MHP and subsequently early treatment.
Supporting information
S1 Table [docx]
Contains seven additional tables with results (Table A-G).
Zdroje
1. Polanczyk GV, Salum GA, Sugaya LS, Caye A, Rohde LA. Annual Research Review: A meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. J Child Psychol Psychiatry. 2015;56: 345–365. doi: 10.1111/jcpp.12381 25649325
2. Sawyer MG, Hazell PL. Health-Related Quality of Life of Children and Adolescents With Mental Disorders. J AM ACAD CHILD ADOLESC PSYCHIATRY. 2002; 8.
3. Costello EJ, Copeland W, Angold A. Trends in psychopathology across the adolescent years: What changes when children become adolescents, and when adolescents become adults?: Trends in psychopathology across the adolescent years. J Child Psychol Psychiatry. 2011;52: 1015–1025. doi: 10.1111/j.1469-7610.2011.02446.x 21815892
4. Copeland WE, Adair CE, Smetanin P, Stiff D, Briante C, Colman I, et al. Diagnostic transitions from childhood to adolescence to early adulthood. J Child Psychol Psychiatry. 2013;54: 791–799. doi: 10.1111/jcpp.12062 23451804
5. Reef J, van Meurs I, Verhulst FC. Children’s Problems Predict Adults’ DSM-IV Disorders Across 24 Years. Adolesc PSYCHIATRY. 2010;49: 8.
6. Hill RM, Pettit JW, Lewinsohn PM, Seeley JR, Klein DN. Escalation to Major Depressive Disorder among Adolescents with Subthreshold Depressive Symptoms: Evidence of Distinct Subgroups at Risk. J Affect Disord. 2014;158: 133–138. doi: 10.1016/j.jad.2014.02.011 24655777
7. Shankman SA, Lewinsohn PM, Klein DN, Small JW, Seeley JR, Altman SE. Subthreshold conditions as precursors for full syndrome disorders: A 15-year longitudinal study of multiple diagnostic classes. J Child Psychol Psychiatry. 2009;50: 1485–1494. doi: 10.1111/j.1469-7610.2009.02117.x 19573034
8. Patton GC, Coffey C, Romaniuk H, Mackinnon A, Carlin JB, Degenhardt L, et al. The prognosis of common mental disorders in adolescents: a 14-year prospective cohort study. The Lancet. 2014;383: 1404–1411. doi: 10.1016/S0140-6736(13)62116-9
9. Copeland WE, Wolke D, Shanahan L, Costello EJ. Adult Functional Outcomes of Common Childhood Psychiatric Problems: A Prospective, Longitudinal Study. JAMA Psychiatry. 2015;72: 892. doi: 10.1001/jamapsychiatry.2015.0730 26176785
10. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62: 593. doi: 10.1001/archpsyc.62.6.593 15939837
11. Arango C, Díaz-Caneja CM, McGorry PD, Rapoport J, Sommer IE, Vorstman JA, et al. Preventive strategies for mental health. Lancet Psychiatry. 2018;5: 591–604. doi: 10.1016/S2215-0366(18)30057-9 29773478
12. Weisz JR, Kuppens S, Ng MY, Eckshtain D, Ugueto AM, Vaughn-Coaxum R, et al. What five decades of research tells us about the effects of youth psychological therapy: A multilevel meta-analysis and implications for science and practice. Am Psychol. 2017;72: 79–117. doi: 10.1037/a0040360 28221063
13. Cross S, Hickie I. Transdiagnostic stepped care in mental health. Public Health Res Pract. 2017;27. doi: 10.17061/phrp2721712 28474049
14. Levitt JM, Saka N, Hunter Romanelli L, Hoagwood K. Early identification of mental health problems in schools: The status of instrumentation. J Sch Psychol. 2007;45: 163–191. doi: 10.1016/j.jsp.2006.11.005
15. Anderson JK, Ford T, Soneson E, Coon JT, Humphrey A, Rogers M, et al. A systematic review of effectiveness and cost-effectiveness of school-based identification of children and young people at risk of, or currently experiencing mental health difficulties. Psychol Med. 2019;49: 9–19. doi: 10.1017/S0033291718002490 30208985
16. Kataoka SH, Zhang L, Wells KB. Unmet Need for Mental Health Care Among U.S. Children: Variation by Ethnicity and Insurance Status. Am J Psychiatry. 2002;159: 1548–1555. doi: 10.1176/appi.ajp.159.9.1548 12202276
17. Sturm R, Ringel JS, Andreyeva T. Geographic Disparities in Children’s Mental Health Care. PEDIATRICS. 2003;112: e308–e308. doi: 10.1542/peds.112.4.e308 14523217
18. Roberts RE, Fisher PW, Blake Turner J, Tang M. Estimating the burden of psychiatric disorders in adolescence: the impact of subthreshold disorders. Soc Psychiatry Psychiatr Epidemiol. 2015;50: 397–406. doi: 10.1007/s00127-014-0972-3 25358512
19. Balázs J, Miklósi M, Keresztény Á, Hoven CW, Carli V, Wasserman C, et al. Adolescent subthreshold-depression and anxiety: psychopathology, functional impairment and increased suicide risk: Adolescent subthreshold-depression and anxiety. J Child Psychol Psychiatry. 2013;54: 670–677. doi: 10.1111/jcpp.12016 23330982
20. Gustafsson J-E, Westling AM, Åkerman A, Eriksson B, Eriksson C, Fischbein L, et al. School, learning and mental health: a systematic review. Stockholm: The Health Committee, Royal Swedish Academy of Sciences; 2010.
21. Kristoffersen JHG, Obel C, Smith N. Gender differences in behavioral problems and school outcomes. J Econ Behav Organ. 2015;115: 75–93. doi: 10.1016/j.jebo.2014.10.006
22. Keilow M, Sievertsen HH, Niclasen J, Obel C. The Strengths and Difficulties Questionnaire and standardized academic tests: Reliability across respondent type and age. Goertz M, editor. PLOS ONE. 2019;14: e0220193. doi: 10.1371/journal.pone.0220193 31344079
23. French MT, Homer JF, Robins PK. What You Do in High School Matters: East Econ J. 2015;41: 370–386.
24. Gevrek D, Gevrek ZE, Guven C. Benefits of Education at the Intensive Margin: Childhood Academic Performance and Adult Outcomes among American Immigrants. East Econ J. 2015;41: 298–328. doi: 10.1057/eej.2015.6
25. Oreopoulos P, Salvanes KG. Priceless: The Nonpecuniary Benefits of Schooling. J Econ Perspect. 2011;25: 159–184. doi: 10.1257/jep.25.1.159
26. Skovgaard AM, Olsen EM, Houmann T, Christiansen E, Samberg V, Lichtenberg A, et al. The Copenhagen County child cohort: Design of a longitudinal study of child mental health. Scand J Public Health. 2005;33: 197–202. doi: 10.1080/14034940510005662 16040460
27. Goodman A, Goodman R. Strengths and Difficulties Questionnaire as a Dimensional Measure of Child Mental Health. J Am Acad Child Adolesc Psychiatry. 2009;48: 400–403. doi: 10.1097/CHI.0b013e3181985068 19242383
28. Goodman R. The Extended Version of the Strengths and Difficulties Questionnaire as a Guide to Child Psychiatric Caseness and Consequent Burden. J Child Psychol Psychiatry. 1999;40: 791. 10433412
29. Goodman R, Meltzer H, Bailey V. The strengths and difficulties questionnaire: A pilot study on the validity of the self-report version. Adolesc Psychiatry. 1998;7: 7.
30. Theunissen MHC, de Wolff MS, Reijneveld SA. The Strengths and Difficulties Questionnaire Self-Report: A Valid Instrument for the Identification of Emotional and Behavioral Problems. Acad Pediatr. 2019;19: 471–476. doi: 10.1016/j.acap.2018.12.008 30639760
31. Nielsen LG, Rimvall MK, Clemmensen L, Munkholm A, Elberling H, Olsen EM, et al. The predictive validity of the Strengths and Difficulties Questionnaire in preschool age to identify mental disorders in preadolescence. Hashimoto K, editor. PLOS ONE. 2019;14: e0217707. doi: 10.1371/journal.pone.0217707 31158249
32. Ortuño-Sierra J, Aritio-Solana R, Fonseca-Pedrero E. Mental health difficulties in children and adolescents: The study of the SDQ in the Spanish National Health Survey 2011–2012. Psychiatry Res. 2018;259: 236–242. doi: 10.1016/j.psychres.2017.10.025 29091822
33. Goodman R. The Strengths and Difficulties Questionnaire: A Research Note. J Child Psychol Psychiatry. 1997;38: 581–586. doi: 10.1111/j.1469-7610.1997.tb01545.x 9255702
34. Stringaris A, Goodman R. The Value of Measuring Impact Alongside Symptoms in Children and Adolescents: A Longitudinal Assessment in a Community Sample. J Abnorm Child Psychol. 2013;41: 1109–1120. doi: 10.1007/s10802-013-9744-x 23677767
35. Meltzer H, Gatward R, Goodman R, Ford T. The Mental Health of Children and Adolescents in Great Britain: (622732007–001) [Internet]. American Psychological Association; 2000.
36. Woerner W, Becker A, Rothenberger A. Normative data and scale properties of the German parent SDQ. Eur Child Adolesc Psychiatry. 2004;13. doi: 10.1007/s00787-004-2002-6 15243780
37. Arnfred J, Svendsen K, Rask C, Jeppesen P, Fensbo L, Houmann T, et al. Danish norms for the Strengths and Difficulties Questionnaire. Dan Med J. 2019;66.
38. Jensen VM, Rasmussen AW. Danish education registers. Scand J Public Health. 2011;39: 91–94. doi: 10.1177/1403494810394715 21775362
39. Ministry of Education. 7-point grading scale [Internet]. 2017 [cited 12 Nov 2018]. http://eng.uvm.dk/general-overview/7-point-grading-scale
40. Danmarks Statistik. Forbrugerprisindeks [Internet]. 2018 [cited 3 Jul 2018]. https://dst.dk/da/Statistik/emner/priser-og-forbrug/forbrugerpriser/forbrugerprisindeks
41. Danske Regioner. Pris- og lønudvikling 1988–2018 fordelt på løn og priser [Internet]. 2018 [cited 3 Jul 2018]. http://regioner.dk/aftaler-og-oekonomi/oekonomisk-vejledning/oekonomisk-vejledning-2018
42. Sahl Andersen J, De Fine Olivarius N, Krasnik A. The Danish National Health Service Register. Scand J Public Health. 2011;39: 34–37. doi: 10.1177/1403494810394718 21775348
43. Wallach Kildemoes H, Toft Sørensen H, Hallas J. The Danish National Prescription Registry. Scand J Public Health. 2011;39: 38–41. doi: 10.1177/1403494810394717 21775349
44. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011;39: 30–33. doi: 10.1177/1403494811401482 21775347
45. Wechsler David. WISC-IV : Technical and Interpretive Manual 4th edition. San Antonio, TX: The Psychological Corporation; 2003.
46. Deb P, Norton EC, Manning WG Jr.. Health Econometrics Using Stata. Stata Press; 2017.
Článek vyšel v časopise
PLOS One
2019 Číslo 10
- Řekněte mi, co jíte, a já vám řeknu, jaká je úroveň vaší kognice
- Původní český test ALBA pro odhalení mírných kognitivních deficitů získal certifikaci MZ ČR
- Duševní onemocnění se u teenagerů přenáší v rámci školní třídy
- Od kostiček k lidské kůži. Jak si postavit 3D biotiskárnu?
- Prof. Libor Grubhoffer: Nová varianta mpox je příležitostí pokročit v poznání původce varioly
Nejčtenější v tomto čísle
- Correction: Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study
- Combining CDK4/6 inhibitors ribociclib and palbociclib with cytotoxic agents does not enhance cytotoxicity
- Risk factors associated with IgA vasculitis with nephritis (Henoch–Schönlein purpura nephritis) progressing to unfavorable outcomes: A meta-analysis
- Prevalence of pectus excavatum (PE), pectus carinatum (PC), tracheal hypoplasia, thoracic spine deformities and lateral heart displacement in thoracic radiographs of screw-tailed brachycephalic dogs